Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

XERS

Xeris Biopharma Holdings, Inc.

CIK 0001867096 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$8.62
↓ 0.05 (-0.58%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Options

Key stats

Market Cap
$1.49B
P/E Ratio
123.93
EPS
0.00
Dividend Yield
Not covered
52W Position
72%
Beta
0.75

Valuation multiples

Fwd P/E
100.00
PEG
Not covered
P/B
114.38
P/S
4.73
EV/Revenue
5.07
ROE
92.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 72%
$4.82$10.08

Latest Financials

2025-12-31 FY
Revenue
$291.85M
Net Income
$554.00K
Total Assets
$383.53M
Free Cash Flow
–

Recent news